Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0
|
作者：
Lord H. [1 ,2 ]
机构：
[1] University of Montréal, Montréal, Que.
[2] Maisonneuve Rosemont, University of Montréal, Montréal, Que. HIT 2M4
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Sirolimus; Risedronate; Mycophenolate Mofetil; Graft Function; Darbepoetin Alfa;
D O I：
10.2165/00003495-200666002-00004
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：11 / 13
页数：2
相关论文
共 50 条
  • [1] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
    Tuncer M.
    Drugs, 2006, 66 (Suppl 2) : 9 - 10
  • [2] Complete Resolution of Severe Diarrhoea after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient at High Immunological Risk
    Thomas Breidenbach
    Marcus Spangenberg
    Eckhard Nagel
    Drugs, 2006, 66 (Suppl 2) : 25 - 27
  • [3] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
    Rohrlich P.-S.
    Deconinck E.
    Cahn J.-Y.
    Plouvier E.
    Drugs, 2006, 66 (Suppl 2) : 33 - 35
  • [4] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease
    Kuhnowski F.
    Terriou L.
    Magro L.
    Jouet J.-P.
    Yakoub-Agha I.
    Drugs, 2006, 66 (Suppl 2) : 29 - 31
  • [5] Gastrointestinal Quality of Life Improvement of Renal Transplant Recipients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Drugs or Agents: Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium
    Ortega, Francisco
    Sanchez-Fructuoso, Ana
    Maria Cruzado, Jose
    Carlos Gomez-Alamillo, Juan
    Alarcon, Antonio
    Pallardo, Lluis
    Maria Morales, Jose
    Oliver, Juan
    Guinea, Guillermo
    TRANSPLANTATION, 2011, 92 (04) : 426 - 432
  • [6] Resolution of severe anaemia and hypotension secondary to rectal ulcers in a renal transplant patient after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
    Ortega F.
    Baltar J.
    Drugs, 2006, 66 (Suppl 2) : 23 - 24
  • [7] Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in Patients with Gastrointestinal Side Effects: Case Studies
    Anita Boswell
    Magdi Shehata
    Drugs, 2006, 66 (Suppl 2) : 19 - 22
  • [8] Changes in the Small Bowel of Symptomatic Kidney Transplant Recipients Converted from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium
    Bunnapradist, Suphamai
    Sampaio, Marcelo S.
    Wilkinson, Alan H.
    Phuong-Thu Pham
    Huang, Edmund
    Kuo, Hung-Tien
    Anastasi, Bishoy
    Danovitch, Gabriel M.
    Lo, Simon K.
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (02) : 184 - 190
  • [9] Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus
    Doukaki, Spyridoula
    Platamone, Andrea
    Alaimo, Roberta
    Bongiorno, Maria Rita
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (01) : 67 - 72
  • [10] Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil
    Arns, W
    Breuer, S
    Choudhury, S
    Taccard, G
    Lee, J
    Binder, V
    Roettele, J
    Schmouder, R
    CLINICAL TRANSPLANTATION, 2005, 19 (02) : 199 - 206
12345